The information highlighted (if any) are the most recent updates for this brand.
Zemidapa is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus: to improve glycaemic control when metformin and one of the monocomponents of Zemidapa do not provide adequate glycaemic control; when already being treated with the free combination of dapagliflozin and gemigliptin.